Home/Filings/4/0001104659-24-034093
4//SEC Filing

Yablonka Uri 4

Accession 0001104659-24-034093

CIK 0001137883other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 8:56 PM ET

Size

5.5 KB

Accession

0001104659-24-034093

Insider Transaction Report

Form 4
Period: 2024-03-11
Yablonka Uri
DirectorChief Operating Officer
Transactions
  • Award

    Common Stock

    2024-03-11+109,426126,969 total
Footnotes (1)
  • [F1]The grant of restricted stock awards ("RSAs") to the Reporting Person as reported herein was approved by the board of directors of the Issuer on March 11, 2024 ("Grant Date") as part of the Issuer's grant of equity awards in the ordinary course. The RSAs shall vest in equal yearly installments over the course of two (2) years, with vesting occurring on each of the first and second anniversary of the Grant Date.

Issuer

BRAINSTORM CELL THERAPEUTICS INC.

CIK 0001137883

Entity typeother

Related Parties

1
  • filerCIK 0001608814

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 8:56 PM ET
Size
5.5 KB